GlassScriptPhysician profile
Ali Y Hamidi
NPI 1518254663
$462.63
in general payments reported to CMS, 2019-2025
6 companies · $61.69 in 2025
The $61.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.49 · 2020: $72.85 · 2021: $88.11 · 2022: $99.54 · 2023: $94.64 · 2024: $23.31 · 2025: $61.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $279.18 | 2022-2025 | Kimyrsa, Rezzayo, Vabomere |
| Abbvie INC. | $53.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $49.82 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $43.95 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $22.20 | 2020 | |
| Allergan, INC. | $14.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Hamidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.